| Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label … RW van Der Pluijm, R Tripura, RM Hoglund, AP Phyo, D Lek, A Ul Islam, ... The Lancet 395 (10233), 1345-1360, 2020 | 254 | 2020 |
| Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination CG Jacob, N Thuy-Nhien, M Mayxay, RJ Maude, HH Quang, ... Elife 10, e62997, 2021 | 90 | 2021 |
| How can interventions that target forest-goers be tailored to accelerate malaria elimination in the Greater Mekong Subregion? A systematic review of the qualitative literature SD Nofal, TJ Peto, B Adhikari, R Tripura, J Callery, TM Bui, L Von Seidlein, ... Malaria journal 18, 1-10, 2019 | 86 | 2019 |
| Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label … TJ Peto, R Tripura, JJ Callery, D Lek, HDT Nghia, C Nguon, NTH Thuong, ... The Lancet Infectious Diseases 22 (6), 867-878, 2022 | 52 | 2022 |
| Forest work and its implications for malaria elimination: a qualitative study N Sanann, TJ Peto, R Tripura, JJ Callery, C Nguon, TM Bui, SD Nofal, ... Malaria journal 18, 1-11, 2019 | 51 | 2019 |
| Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning D Das, R Vongpromek, T Assawariyathipat, K Srinamon, K Kennon, ... Malaria Journal 21 (1), 122, 2022 | 41 | 2022 |
| Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled … WHK Schilling, P Jittamala, JA Watson, S Boyd, V Luvira, T Siripoon, ... The Lancet Infectious Diseases 24 (1), 36-45, 2024 | 36 | 2024 |
| Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the Greater Mekong Subregion M Imwong, K Suwannasin, S Srisutham, R Vongpromek, C Promnarate, ... Antimicrobial agents and chemotherapy 65 (12), 10.1128/aac. 01121-21, 2021 | 35 | 2021 |
| Tools to accelerate falciparum malaria elimination in Cambodia: a meeting report D Lek, JJ Callery, C Nguon, M Debackere, S Sovannaroth, R Tripura, ... Malaria Journal 19, 1-12, 2020 | 33 | 2020 |
| Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial R Tripura, L von Seidlein, S Sovannaroth, TJ Peto, JJ Callery, M Sokha, ... The Lancet Infectious Diseases 23 (1), 81-90, 2023 | 28 | 2023 |
| The feasibility and acceptability of mass drug administration for malaria in Cambodia: a mixed-methods study TJ Peto, R Tripura, N Sanann, B Adhikari, J Callery, M Droogleever, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 112 (6 …, 2018 | 25 | 2018 |
| Engaging ethnic minority communities through performance and arts: health education in Cambodian forest villages JJ Callery, N Sanann, R Tripura, T Buntau, TJ Peto, P Kunthea, C Pell, ... International Health 13 (2), 188-195, 2021 | 23 | 2021 |
| Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project A Chandna, R Chew, NSN Htun, TJ Peto, M Zhang, M Liverani, ... Wellcome open research 6, 64, 2022 | 22 | 2022 |
| Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia B Adhikari, R Tripura, L Dysoley, JJ Callery, TJ Peto, C Heng, T Vanda, ... Malaria Journal 21 (1), 282, 2022 | 21 | 2022 |
| Acceptability and feasibility of malaria prophylaxis for forest goers: findings from a qualitative study in Cambodia M Jongdeepaisal, M Ean, C Heng, T Buntau, R Tripura, JJ Callery, ... Malaria Journal 20, 1-15, 2021 | 19 | 2021 |
| Village malaria workers for the community-based management of vivax malaria B Adhikari, R Tripura, TJ Peto, JJ Callery, L von Seidlein, L Dysoley, ... The Lancet Regional Health-Southeast Asia 9, 2023 | 16 | 2023 |
| Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial V Luvira, WHK Schilling, P Jittamala, JA Watson, S Boyd, T Siripoon, ... BMC Infectious Diseases 24 (1), 89, 2024 | 14 | 2024 |
| Clinical antiviral efficacy of remdesivir in coronavirus disease 2019: an open-label, randomized controlled adaptive platform trial (PLATCOV) P Jittamala, WHK Schilling, JA Watson, V Luvira, T Siripoon, ... The Journal of Infectious Diseases 228 (10), 1318-1325, 2023 | 14 | 2023 |
| Pharmacometrics of high dose ivermectin in early COVID-19: an open label, randomized, controlled adaptive platform trial (PLATCOV) WHK Schilling, P Jittamala, JA Watson, M Ekkapongpisit, T Siripoon, ... Elife 12, 2023 | 13 | 2023 |
| Artemisinin-resistant malaria in Africa demands urgent action M Dhorda, A Kaneko, R Komatsu, A Kc, S Mshamu, S Gesase, ... Science 385 (6706), 252-254, 2024 | 12 | 2024 |
Thomas J PetoEpidemiologist, University of OxfordVerified email at ndm.ox.ac.uk
